AVITA medical announces commencement of randomized controlled clinical study of RECELL system in treatment of children with burn injuries
from Associated Press via Business Wire
AVITA Medical, a global regenerative medicine company, announced that the commencement of a randomized, controlled clinical study of the RECELL® Autologous Cell Harvesting Device (RECELL® System) in the treatment of significant superficial partial- and mid-thickness pediatric burns, including scald injuries.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063